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Abstract: Adherence to the American Cancer Society’s (ACS) Nutrition and Physical Activity Cancer
Prevention Guidelines is associated with reductions in overall cancer incidence and mortality,
including site-specific cancers such as colorectal cancer. We examined the relationship between
baseline adherence to the ACS guidelines and (1) baseline adenoma characteristics and (2) odds of
recurrent colorectal adenomas over 3 years of follow-up. Cross-sectional and prospective analyses
with a pooled sample of participants from the Wheat Bran Fiber (n = 503) and Ursodeoxycholic
Acid (n = 854) trials were performed. A cumulative adherence score was constructed using
baseline self-reported data regarding body size, diet, physical activity and alcohol consumption.
Multivariable logistic regression demonstrated significantly reduced odds of having three or more
adenomas at baseline for moderately adherent (odds ratio [OR] = 0.67, 95% confidence intervals [CI]:
0.46–0.99) and highly adherent (OR = 0.50, 95% CI: 0.31–0.81) participants compared to low adherers
(p-trend = 0.005). Conversely, guideline adherence was not associated with development of recurrent
colorectal adenoma (moderate adherence OR = 1.16, 95% CI: 0.85–1.59, high adherence OR = 1.23,
95% CI: 0.85–1.79).
Keywords: adherence; colorectal adenoma; cancer prevention guidelines; diet; physical activity
1. Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading
cause of cancer mortality among men and women in the United States [1]. Despite decreasing incidence
rates for colorectal cancer over the past two decades in the United States among men and women
aged 50 years and older, the American Cancer Society (ACS) estimates that there will have been 95,520
new cases of colon cancer and 39,910 new cases of rectal cancer diagnosed in 2017, with 49,190 deaths
from these malignancies [2]. Increased screening rates among those aged 50 years and older have
contributed to the reduction in colorectal cancer rates over the past 20 years in this age group through
early detection and removal of adenomatous polyps, the precursors to colorectal cancer [3,4]. However,
over the same time period there has been a progressive increase in colorectal cancer incidence in
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individuals without a known genetic predisposition to the disease in individuals under the age of
50 years [5].
Approximately 96% of colorectal cancers are adenocarcinomas, which develop in colorectal
epithelial cells [6]. Adenomas, the most common type of colorectal polyp, are benign neoplasms that
up to 50% of all individuals will develop in their lifetime [7,8]. However, adenomas typically cause
no symptoms and a minority may progress asymptomatically to cancer unless removed. The United
States Preventive Services Task Force (USPSTF) recommends that adults aged 50 to 75 years should be
screened for colorectal cancer every 1–10 years depending on the specific screening test and personal
risk factors. However, it is currently estimated that only half of those recommended for colorectal
screening are following these guidelines [9]. In order to prevent CRC in those unable or unwilling
to undergo the current colorectal screening procedures, further strategies for preventing colorectal
neoplasia are essential.
There are several innate factors that may increase the risk of colorectal cancer [9] but there are
also several modifiable risk factors for CRC such as physical inactivity, overweight and obesity [10].
Overconsumption of energy-rich foods, high consumption of red and/or processed meat, deficiency in
some micronutrients or phytochemicals, moderate to heavy alcohol consumption and smoking early
in life [10] have been shown to increase the risk for CRC [10].
Nutrition and physical activity guidelines for cancer prevention have been designed by the United
States Department of Health and Human Services along with leading cancer organizations in order
to provide recommendations for addressing these factors [11,12]. Our recent systematic review of
12 large cohort studies [13] found that participants following behavior-associated cancer prevention
guidelines for modifiable factors, such as body weight, physical activity, diet and alcohol consumption,
had a reduced risk of cancer incidence, cancer mortality and all-cause mortality [11,12]. However,
to date, the association between following American Cancer Society (ACS) or other healthy-lifestyle
recommendations and odds for the development of colorectal cancer precursor lesions has not been
addressed. The present study assesses the relationship between adherence to the ACS nutrition and
physical activity cancer prevention guidelines and (1) baseline adenoma characteristics (histology, size,
multiplicity) and (2) new (recurrent) colorectal adenoma occurrence.
2. Materials and Methods
2.1. Study Population
We pooled data from two randomized, controlled, double blind, Phase III clinical trials conducted
at the University of Arizona Cancer Center (UACC). The effect of either wheat bran fiber (WBF) [14] or
ursodeoxycholic acid (UDCA) [15] was evaluated against the development of a recurrent colorectal
adenoma. The present analyses were conducted for 1357 participants in the pooled sample with
complete data for baseline adenoma characteristics, diet and physical activity measures and follow-up
for evaluation of recurrent colorectal adenomas. The University of Arizona Human Subjects Protection
Program previously approved both studies. Each participant provided written informed consent prior
to trial enrollment.
Recruitment and Data Collection: Participants were originally recruited from Phoenix and Tucson
gastroenterology practices from 1990–1995 for WBF and 1995–1999 for UDCA. Inclusion criteria
included men and women aged 40 to 80 years who had at least one adenoma (≥3 mm) removed
via a colonoscopy within 6-months prior to study enrollment. Mean time from trial randomization
to follow-up colonoscopy was 3.1 and 3.2 years for the WBF and UDCA trials, respectively [14,15].
WBF trial participants were randomized to a daily wheat bran fiber supplement (13.5 g/day) or a
low-fiber supplement (2.0 g/day); UDCA trial participants were randomized to receive 8–10 mg UDCA
per kilogram of body weight or placebo [15]. Primary findings demonstrated that neither the WBF
supplement nor the UDCA treatment reduced the number of recurrent colorectal adenomas [15,16].
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2.2. Outcome Ascertainment
Medical records and pathology reports were used to collect baseline and recurrent adenoma
characteristics such as number, size, location and histology [14,15]. Presence of a recurrent colorectal
adenoma was defined as yes or no. Advanced colorectal adenoma is defined as an adenoma >1 cm
in size or an adenoma of any size with tubulovillous or villous histology. Advanced adenomas
are those at greatest risk for progression to colorectal cancer. Metachronous adenoma risk, that is,
the development of recurrent adenoma following adenoma resection (polypectomy), is increased in
individuals with baseline advanced adenoma compared to those with non-advanced adenoma and
metachronous (recurrent) adenoma risk is also increased in individuals with >2 non-advanced baseline
adenoma [17,18].
2.3. Nutrition and Physical Activity Cancer Prevention Guidelines Score
An a priori adherence score was constructed, based upon previous work [13], for adherence to the
2012 ACS cancer prevention guidelines for nutrition and physical activity [12]. The guidelines focused
on an overall pattern of lifestyle behaviors that included body weight, physical activity, diet and
alcohol consumption. Frequency questionnaires were used to collect baseline diet and physical activity
data from 1990–1992 for WBF and 1995–1996 for UDCA. Diet was assessed utilizing the Arizona
Food Frequency Questionnaire (AFFQ), which is a semi-quantitative, 175-item validated questionnaire
that queries participants to report how often and how much they consumed each food item over the
past 12-month period [19]. Physical activity was assessed utilizing the Arizona Activity Frequency
Questionnaire (AAFQ), a 59-item, validated questionnaire that asks participants about usual physical
activity in the past four weeks [20].
Adherence scores were based upon equally weighted ACS recommendations on a 0–2 point scale
(not meeting the recommendation at all = 0 points, partially meeting the recommendation = 1 point,
fully meeting the recommendation = 2 points). The overall score, summed from individual
recommendations, ranged from not adherent at all to the recommendations (0 points) to fully adherent
to all four lifestyle factor recommendations (8 points). Adherence scores were categorized into low
(0–2 points), moderate (3–5 points) and high (6–8 points). Recommendations for each lifestyle factor,
how they were measured, how scores were assigned based upon the guidelines and the proportion
of the study sample within each adherence score category are shown in Table 1. Although the ACS
guidelines recommend choosing whole grains over refined grains, the proportion of whole grain
consumption was not included in the adherence score for these analyses because (1) grains-related
questions in the food frequency questionnaire were vague in distinguishing whole versus refined
grains and (2) the food frequency questionnaire was updated between the WBF and UDCA trials,
which could have led to misclassification. Smoking status was not included in the adherence score but
was included as a potential confounder in the current analyses.
Table 1. Components of the guideline adherence score and distribution in the study sample.
Score Description Alln (%)
Overall adherence score Low 0–2 points 204 (12.2)
Moderate 3–5 points 1147 (68.7)
High 6–8 points 319 (19.1)
Adherence score component
Body mass index (BMI) 0 >30 kg/m2 476 (28.5)
1 >25–≤30 kg/m2 749 (44.9)
2 18.5–≤25 kg/m2 445 (26.7)
Nutrients 2018, 10, 1098 4 of 11
Table 1. Cont.
Score Description Alln (%)
Physical Activity (PA) 0 <8.75 MET h/week 658 (39.4)
1 8.75–17.5 MET h/week 421 (25.2)
2 >17.5 MET h/week 591 (35.4)
Overall Diet 1 0 0–1 sub-score sum 209 (12.5)
1 2–4 sub-score sum 947 (56.7)
2 5–6 sub-score sum 514 (30.8)
Fruit & Vegetables sub-score 0 <5 servings/day fruits plus veg 836 (50.1)
1 ≥5 servings/day fruits plus veg 834 (49.9)
Quality sub-score 0 1st tertile of total carotenoids 540 (32.3)
1 2nd tertile of total carotenoids 564 (33.8)
2 3rd tertile of total carotenoids 566 (33.9)
Red & processed meat sub-score 0 Highest quartile 421 (25.2)
1 423 (25.3)
2 420 (25.2)
3 Lowest quartile 406 (24.3)
Alcohol 0 Men ≥3, Women ≥2 drinks/day 153 (9.2)
1 Men 1–2, Women 1 drink/day 921 (55.2)
2 Non-drinker 596 (35.7)
1 Overall Diet score is generated from the summation of the fruit & vegetable, quality and red & processed meat
sub-scores then collapsed into 3 categories (0–1, 2–4, 5–6) for subsequent overall diet adherence scores (0, 1, 2).
Maintaining a healthy body weight was scored based upon body mass index (BMI, in kg/m2)
from height and weight reported at baseline. Fully meeting the recommendation (2 points) was given
to those with a BMI within normal range (18.5–25 kg/m2). Not meeting the recommendation at all
(0 points) was given to those with a BMI in the obese category (>30.0 kg/m2). One point was given
to those partially meeting the recommendation with a BMI in the overweight range (25–30 kg/m2).
Underweight participants (<18.5 kg/m2) were excluded from the present analysis.
Adopting a physically active lifestyle was evaluated by MET [21] scores from the AFFQ
recreational activities section. The minimum standard of 30 min on 5 days (2.5 h/week) of moderate
activity (3.5 METs) is equal to 8.75 MET-hours per week. Any participant performing less than
8.75 MET-hours per week received a score of zero points for not meeting the recommendation
at all. One hour per day, 5 days a week (5.0 h/week), of moderate activity (3.5 METs) is equal
to 17.5 MET-hours/week. Therefore, 8.75 to 17.5 MET-hours/week was considered partially
meeting the recommendation and received 1 point. Meeting “preferable” levels of greater than
17.5 MET-hours/week received 2 points for fully meeting the recommendation.
Consumption of a healthy diet with an emphasis on plant sources was assessed with three
sub-scores that were constructed and summed to capture the recommended dietary pattern. For the
first diet sub-score, 1 point was assigned for meeting the recommended number of 5 servings of
fruits and vegetables each day. The number of servings was measured from the following food group
categories: Fruits, Fruit Juice, Vegetables and Vegetable Juice. One or 2 points were assigned for
diet quality based upon being in the 2nd or 3rd sex-specific tertile of total carotenoids, respectively,
which included beta carotene, alpha carotene, beta cryptoxanthin, lycopene and lutein plus zeaxanthin
combined. Limiting the consumption of processed and red meats was assessed with a sex-specific
quartile distribution with the lowest quartile receiving 3 points and the highest quartile receiving
zero points. The diet sub-scores were summed for a potential total of 6 points. Dietary pattern scores
were further collapsed into 0 points for those with 0–1 summed diet scores, 1 point for those with
2–4 summed diet scores and 2 points for those with 5–6 summed diet scores.
Alcohol consumption was captured in the AFFQ in terms of total grams of alcohol per day. One
drink was estimated as 14 g of alcohol or approximately a 12 ounce regular beer, 5 ounce glass of
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wine, or 1.5 ounce shot of 80-proof distilled spirit [22]. Nondrinkers were assigned 2 points, moderate
drinkers consuming the limit or less (1 drink per day for women or 2 drinks per day for men) were
assigned 1 point and heavy drinkers consuming more than the limit were assigned zero points.
2.4. Statistical Analysis
Descriptive statistics were generated for outcome variables, exposure variables and demographic
variables. Chi-square tests were used to test associations of the chosen variables for participants
with and without adenoma recurrence and for recurrent subjects stratified by sex. Current literature
suggests potential confounders include age, previous polyps, family history of colorectal adenomas
and/or cancer and aspirin use [23–25]. Additional covariates were examined and included if the
measure of association changed by at least 10% when entered in the model [26]. Multiple logistic
regression models were utilized to assess the association of adherence score with adenoma recurrence
and to evaluate potential interaction between adherence score and (1) sex as a biological variable (2)
study and (3) smoking. Statistical significance was determined at an α level of 0.05 utilizing two-sided
tests. Data from the trials were merged and managed using Stata version 14.1 software (StataCorp LP,
College Station, TX, USA).
3. Results
Table 1 demonstrates high adherence to the guidelines was achieved by 19.1% of the sample
population while 12.2% and 68.7% attained low and moderate adherence, respectively. Baseline
characteristics by category of adherence score are shown in Table 2. In general, the proportion of those
in the highest versus the lowest categories of adherence did not vary by age or race, though there was
a greater percentage of college graduates among those in the high adherence group (35.4%) compared
to the low adherence group (29.4%). Highly adherent participants were also more likely to have a
lower BMI and to perform more physical activity than those in the low adherence category.
Table 2. Baseline characteristics of participants in the pooled sample, by categories of adherence 1.
Adherence Score Category (Points)
0–2 3–5 6–8
n (%) 204 (12.2) 1147 (68.7) 319 (19.1)
Age, years 2 62.8 ± 8.4 65.8 ± 8.6 68.0 ± 8.1 *
White, n (%) 195 (95.6) 1085 (94.6) 303 (95.0)
College graduate, n (%) 60 (29.4) 409 (35.7) 113 (35.4)
BMI, kg/m2 32.5 ± 4.4 28.2 ± 4.3 24.5 ± 2.7 *
Physical activity, MET-h/week 4.1 ± 5.0 16.7 ± 29.2 31.3 ± 32.2 *
Diet
Total energy, kcal/day 2135 ± 797 1955 ± 757 1946 ± 726 *
Fruit and veg, servings/day 5.0 ± 3.3 5.7 ± 3.7 6.9 ± 3.7 *
Total carotenoids, mg/day 13.4 ± 9.1 13.8 ± 8.7 15.1 ± 7.4 *
Red and processed meat, servings/day 2.0 ± 1.0 1.4 ± 0.8 1.1 ± 0.7 *
Alcohol
Nondrinker at baseline, n (%) 22 (10.8) 391 (34.1) 183 (57.4) *
Intake among drinkers, drinks/day 1.3 ± 1.7 0.8 ± 1.2 0.7 ± 0.7 *
Current smoker, n (%) 34 (16.7) 137 (11.9) 38 (11.9)
Family history CRC, n (%) 51 (25.0) 267 (23.3) 66 (20.7)
Previous polyps, n (%) 78 (38.2) 489 (42.6) 131 (41.1)
Aspirin use in last 4 weeks, n (%) 49 (24.0) 340 (29.6) 113 (35.4) *
Number of colonoscopies during study period 1.8 ± 0.8 1.8 ± 0.8 1.8 ± 0.9
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Table 2. Cont.
Adherence Score Category (Points)
0–2 3–5 6–8
Baseline adenoma characteristics
Multiplicity, ≥3 adenomas, n (%) 42 (15.0) 192 (68.3) 47 (16.7)
Large size, >1cm, n (%) 89 (13.1) 463 (67.9) 130 (19.1)
Tubulovillous/villous histology, n (%) 49 (14.1) 228 (65.5) 71 (20.4)
Proximal location, n (%) 109 (12.8) 594 (69.6) 150 (17.6)
1 Some percentages do not add up to 100% because of missing data or rounding. BMI, body mass index;
MET-h/week, metabolic equivalent hours per week; CRC, colorectal cancer. 2 Mean ± SD (all such values).
* p-value < 0.05. Non-parametric test for trend for continuous variables and ANOVA for categorical variables.
Table 3 presents the adjusted odds ratios for the association between adherence score categories
and baseline (prevalent) colorectal adenoma characteristics from multivariate logistic regression
models. In the pooled sample, reduced odds of having three or more prevalent adenomas at baseline
were shown for moderately adherent (OR = 0.67, 95% CI: 0.46–0.99) and highly adherent (OR = 0.50,
95% CI: 0.31–0.81) participants compared to those with low adherence (p-trend = 0.005). No statistically
significant associations were shown between guideline adherence and baseline (prevalent) adenoma
size or villous histology in the pooled sample. No heterogeneity of effect was demonstrated between
sexes for the relationship between adherence score category and any of the baseline (prevalent)
adenoma characteristics.
Table 4 presents the association between metachronous (recurrent) colorectal adenoma and
adherence score category from multivariate logistic regression models. In the pooled sample, there
were no statistically significant associations between guideline adherence and development of a new
adenoma upon follow-up. The odds of having a recurrent colorectal adenoma were 1.16 times (95% CI:
0.85–1.59) greater for those who were moderately adherent to the guidelines and 1.23 times greater (95%
CI: 0.85–1.79) for those individuals who had high adherence compared to those with low adherence
but this finding was not statistically significant. No significant interactions were observed by sex.
Table 3. Adjusted ORs (95% CI) for the association between category of guideline adherence and
baseline colorectal adenoma characteristics for pooled sample and by sex and study.
Baseline Adenoma Characteristics (OR, 95% CI) 1
Acs Adherence Score Category Multiplicity (≥3 Adenoma) Large Size (≥1 cm) Villous Histology
n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI)
Pooled sample
Low (0–2) 204 (12.2) 1.00 89 (13.1) 1.00 49 (14.1) 1.00
Moderate (3–5) 1147 (68.7) 0.67 (0.46–0.99) 463 (67.9) 0.85 (0.63–1.15) 228 (65.5) 0.78 (0.55–1.11)
High (6–8) 319 (19.1) 0.50 (0.31–0.81) 130 (19.1) 0.85 (0.59–1.22) 71 (20.4) 0.89 (0.58–1.36)
p-Trend 0.005 0.455 0.765
Men
Low (0–2) 141 (12.3) 1.00 57 (12.3) 1.00 34 (14.5) 1.00
Moderate (3–5) 791 (68.7) 0.62 (0.40–0.97) 319 (69.1) 0.92 (0.64–1.34) 153 (65.4) 0.73 (0.47–1.12)
High (6–8) 219 (19.0) 0.47 (0.27–0.82) 86 (18.6) 0.83 (0.53–1.30) 47 (20.1) 0.78 (0.46–1.30)
p-Trend 0.011 0.405 0.443
Women
Low (0–2) 63 (12.1) 1.00 32 (14.6) 1.00 15 (13.2) 1.00
Moderate (3–5) 356 (68.6) 0.82 (0.38–1.79) 144 (65.5) 0.68 (0.40–1.17) 75 (65.8) 0.90 (0.48–1.70)
High (6–8) 100 (19.3) 0.56 (0.21–1.48) 44 (20.0) 0.85 (0.45–1.60) 24 (21.1) 1.16 (0.55–2.45)
p-Trend 0.221 0.809 0.577
p-Interaction 2 0.8360 0.4363 0.8597
1 ORs adjusted for age, sex (except for stratified analysis) and study (except for stratified analysis), 2 p for interaction
calculated by likelihood ratio test.
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Table 4. Adjusted ORs (95% CIs) for the association between category of adherence and recurrent colorectal adenoma occurrence for pooled sample and by sex
and study.
Recurrent Adenoma Occurrence (OR, 95% CI) 1
Adherence Score Category Any Recurrent Adenoma Multiplicity (≥3 Adenoma) Large Size (≥1 cm) Villous Histology
n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI)
Pooled sample
Low (0–2) 105 (13.8) 1.00 22 (11.2) 1.00 14 (8.4) 1.00 11 (9.2) 1.00
Moderate (3–5) 504 (66.2) 1.16 (0.85–1.59) 130 (66.0) 0.97 (0.58–1.59) 112 (67.1) 1.40 (0.78–2.51) 88 (73.3) 1.35 (0.70–2.58)
High (6–8) 152 (20.0) 1.23 (0.85–1.79) 45 (22.8) 1.11 (0.62–1.98) 41 (24.6) 1.83 (0.95–3.51) 21 (17.5) 1.08 (0.50–2.33)
p-Trend 0.294 0.611 0.055 0.938
Men
Low (0–2) 67 (11.9) 1.00 18 (11.6) 1.00 12 (9.6) 1.00 10 (11.1) 1.00
Moderate (3–5) 385 (38.4) 1.00 (0.69–1.45) 98 (63.2) 0.85 (0.48–1.49) 85 (68.0) 1.12 (0.59–2.15) 65 (72.2) 1.00 (0.50–2.02)
High (6–8) 111 (19.7) 1.00 (0.64–1.56) 39 (25.2) 1.10 (0.58–2.12) 28 (22.4) 1.27 (0.61–2.67) 15 (16.7) 0.76 (0.32–1.77)
p-Trend 0.983 0.531 0.494 0.435
Women
Low (0–2) 17 (8.6) 1.00 4 (9.5) 1.00 2 (4.8) 1.00 1 (3.3) 1.00
Moderate (3–5) 138 (69.7) 1.69 (0.92–3.09) 32 (76.2) 1.30 (0.43–3.89) 27 (64.3) 2.45 (0.56–10.64) 23 (76.7) 4.42 (0.58–33.38)
High (6–8) 43 (21.7) 2.02 (1.01–4.06) 6 (14.3) 0.92 (0.25–3.40) 13 (31.0) 4.58 (0.98–21.39) 6 (20.0) 4.15 (0.48–35.56)
p-Trend 0.061 0.750 0.021 0.306
p-Interaction 2 0.2152 0.3877 0.3253 0.1281
1 ORs adjusted for age, study (except for stratified analysis), baseline multiplicity (except villous histology analyses) and sex (except for stratified analysis). 2 p for interaction calculated by
likelihood ratio test.
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4. Discussion
The results of the present study demonstrate that adherence to the cancer prevention guidelines
was associated with lower odds of >2 adenomas at baseline. Those who were more adherent to the
guidelines were significantly less likely to have >2 adenomas, which is an established marker of
increased risk for recurrent adenoma and colorectal cancer [27]. In contrast, there were no statistically
significant associations observed for guideline adherence and odds of recurrent adenoma surveillance
colonoscopy 3–5 years later.
To our knowledge, no studies have evaluated the association between ACS guideline adherence
specifically and the risk for precancerous colorectal lesions. However, prior studies have examined
similar indices that include the variables employed in the ACS guidelines [28–30]. In a recent report
by Knudsen et al. [30], the relationship between a lifestyle score and detection of high-risk adenomas,
including multiple lesions, was assessed among more than 6000 Norwegians undergoing either
fecal immunochemical testing or flexible sigmoidoscopy screening [30]. They observed a statistically
significant inverse relationship between number of healthy lifestyle factors, including lower BMI,
greater physical activity and higher fruit and vegetable consumption and odds for the development of
advanced colorectal neoplasia [30].
In a case-control study with 1444 cases and 3764 controls by Fu et al., researchers created a
scale of lifestyle factors such as higher BMI, non-use of NSAIDS, smoking, obesity and low fiber
and calcium intake and found that the more adverse lifestyle factors present, the higher the risk
of both adenomatous and hyperplastic polyps, with similarly increased odds observed for both
non-advanced and advanced lesions, including multiple polyps [29]. Finally, in another case-control
study by Tabung et al. [28], a healthy lifestyle index was created among 143 participants undergoing
colonoscopy. The index included smoking habits, alcohol use, physical activity, BMI and intake of
fat and fruits and vegetables [28]. Overall, they observed no association between number of healthy
behaviors and odds for colorectal neoplasia. However, they found that for participants who reported
no use of NSAIDs, those in the healthy lifestyle category had 72% lower odds of any colorectal adenoma
as compared to those in the unhealthy category (OR 0.28; 95% CI 0.08, 0.98) [28]. In addition, a one-unit
increase in the lifestyle index significantly reduced odds of any adenoma by 53% (OR 0.47; 95% CI
0.26, 0.88) [28]. Taken together, the results of prior studies as well as the present work suggest that
adherence to healthier lifestyle behaviors may have a role in prevention of incident colorectal lesions,
particularly multiple lesions. However, after detection and removal of adenomas, our work suggests
that adherence to the ACS guidelines has no impact on recurrent adenoma rate 3–5 years later.
Another factor which warrants further consideration is that although a statistically significant
association between the adherence score and odds of a recurrent adenoma after polypectomy
was not observed in the present study, recent work has demonstrated a significant reduction in
colorectal cancer risk (27–52%) for those who highly adhere to the ACS guidelines versus those
with low adherence [13,31]. It is possible that the 3–5 year window between baseline and follow-up
colonoscopies among participants in the current work is not long enough to detect an impact of the
cancer prevention guidelines. It may also be that the impact of a healthier lifestyle occurs at a later
stage of the carcinogenesis pathway, rather than in the initiation of a new lesion after colonoscopic
removal. Another possible factor is that our study population’s median baseline age was >60 years.
Perhaps by this age range, epigenetic and other changes related to adverse lifestyle may no longer
be reversible.
The major strengths of the current study include availability of data from a prospective cohort of
over 1300 participants with complete data on a wide range of available baseline nutrition, physical
activity and recurrent colorectal adenoma outcome data. This study is not without limitations.
Self-reported diet and physical activity are susceptible to measurement error or misclassification
bias. In addition, the lifestyle pattern at the time of screening may not reflect participants’ health
behaviors leading up to the onset of their adenoma development. Various behaviors included in the
ACS adherence score may also cluster causing potential challenges in parsing out the contributing
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components. Further, the ACS recommendation “maintenance of a healthy weight throughout life”
could not be precisely assessed because height and weight data were only available at study baseline
rather than for younger ages. Finally, we were unable to adjust for the number of colonoscopies that
occurred prior to study entry and it is possible that those who were more adherent to the guidelines
were more likely to have regular screening colonoscopies and therefore less likely to have multiple
adenomas discovered at the baseline colonoscopy.
5. Conclusions
In summary, these results suggest that following an overall pattern of healthy behaviors as
recommended in the ACS Nutrition and Physical Activity Cancer Prevention guidelines is associated
with a reduction in odds for multiple (>2) non-advanced colorectal adenomas at baseline colonoscopy.
However, no association with adhering to the guidelines and odds of developing a recurrent colorectal
adenoma was observed over the 3–5-year follow-up period in our sample population. This is
an important area for further research as the presence of multiple adenomas increases the risk of
development of CRC. Prevention of multiple adenomas may have an impact on colonoscopy screening
rates as well, as multiplicity is an indicator for more frequent surveillance.
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